|
Name: Butabarbital (secbutabarbital)
Type: Barbiturate
AKA: Butisol, Butibel
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Butabarbital, also known as secbutabarbital, was first synthesized in the early 20th century. It was introduced as a sedative and hypnotic agent. Its use has decreased over time due to the development of newer medications with fewer side effects. Butabarbital's historical significance lies in its role in early sedative therapy and its impact on the development of modern barbiturates.
|
|
V. Legal Information
Butabarbital, a barbiturate, is used as a sedative and hypnotic. It is controlled in many countries, including the United States, where it is classified under Schedule II of the Controlled Substances Act due to its abuse potential. Similar controls exist globally. [Source: UNODC].
US Federal Schedule - III
Schedule III drugs, substances, or chemicals are defined as drugs with a moderate to low potential for physical and psychological dependence. Schedule III drugs abuse potential is less than Schedule I and Schedule II drugs but more than Schedule IV. Some examples of Schedule III drugs are: products containing less than 90 milligrams of codeine per dosage unit (Tylenol with codeine), ketamine, anabolic steroids, testosterone.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Butabarbital (Secbutabarbital) is a barbiturate used as a sedative and hypnotic. It causes sedation and impaired motor function. Short-term use is effective for managing sleep disorders, but long-term use can lead to dependence, cognitive impairment, and significant health issues. Overdose risks include severe sedation and respiratory depression. Safe use involves precise dosing and medical supervision. Recent research emphasizes its efficacy and risks associated with prolonged use.  |
|
VII. Psychological Effects
Butabarbital, a barbiturate, affects GABA receptors, leading to sedation and mood changes. Immediate effects include relaxation and drowsiness, lasting several hours. Long-term use may result in cognitive impairments and dependence. Research focuses on its use as a sedative and associated risks of cognitive effects and psychological dependence.
 |
|
VIII. Culture
Butabarbital (secbutabarbital) is a barbiturate used for its sedative and hypnotic effects, classifying it as a downer. Short-term use induces sedation and sleep, while long-term use can lead to dependence, tolerance, and cognitive impairment. Overdose risks include severe sedation, respiratory depression, and potentially fatal outcomes. Safe dosages are prescribed by medical professionals, typically not exceeding 200 mg per day. Recent research highlights its effectiveness in sedation but warns of high dependence and overdose risks. Physical effects include drowsiness, impaired coordination, and potential respiratory depression.
 |